CME czar goes to Pfizer

Share this article:
Maureen Doyle-Scharff
Maureen Doyle-Scharff
Pfizer, in the midst of revamping its CME department, scored a coup with the recent hiring of Maureen Doyle-Scharff, MBA.

Doyle-Scharff comes from the Ross Products division of Abbott Labs, where for the last two years she directed healthcare education, policy and programs. Her new title at Pfizer is director, medical education, US external medical affairs.

A well-known advocate of CME among all provider groups, Doyle-Scharff holds positions on the boards of several medical education professional groups. Before joining Ross, she was executive director, professional and strategic customer alliances for Johnson & Johnson.

Pfizer's Medical Education Grants department, under the direction of Mike Saxton, MEd, senior director, team leader, is placing more emphasis on the competency of personnel. Earlier this year, the firm made reviewers in the department re-interview for jobs, with candidates required to meet higher standards.

Bringing in someone of high stature, who shares his vision, could put Saxton in a better position to implement his plans, say people familiar with the matter.
Share this article:

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?